Genomic Insights on Variation Underlying Capsule Expression in Meningococcal Carriage Isolates From University Students, United States, 2015-2016.

Neisseria meningitidis capsule carriage mutations variation whole genome sequencing

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2022
Historique:
received: 14 11 2021
accepted: 11 01 2022
entrez: 7 3 2022
pubmed: 8 3 2022
medline: 8 3 2022
Statut: epublish

Résumé

In January and February 2015,

Identifiants

DOI: 10.3389/fmicb.2022.815044 PMID: 35250931 PMC: PMC8893959
pubmed: 35250931
doi: 10.3389/fmicb.2022.815044
pmc: PMC8893959
doi:

Types de publication

Journal Article

Langues

eng

Pagination

815044

Informations de copyright

Copyright © 2022 Whaley, Vuong, Topaz, Chang, Thomas, Jenkins, Hu, Schmink, Steward-Clark, Mathis, Rodriguez-Rivera, Retchless, Joseph, Chen, Acosta, McNamara, Soeters, Mbaeyi, Marjuki and Wang.

Déclaration de conflit d'intérêts

HC, LJ, FH, MM, LR-R, and SJ were employed by the IHRC Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Infect Dis. 2017 Nov 27;216(9):1130-1140
pubmed: 28968661
J Infect Public Health. 2016 Jul-Aug;9(4):506-15
pubmed: 26819097
J Clin Microbiol. 1995 Dec;33(12):3326-7
pubmed: 8586729
PLoS One. 2016 Dec 1;11(12):e0167404
pubmed: 27907129
Pediatr Infect Dis J. 2015 Nov;34(11):1197-202
pubmed: 26222063
J Clin Microbiol. 2016 Jan;54(1):25-34
pubmed: 26311858
Hum Vaccin Immunother. 2017 May 4;13(5):1182-1189
pubmed: 28140784
mSphere. 2016 Nov 16;1(6):
pubmed: 27904879
J Infect. 2015 Jul;71(1):43-52
pubmed: 25709085
Microbes Infect. 2000 May;2(6):687-700
pubmed: 10884620
PLoS One. 2013 Sep 30;8(9):e76932
pubmed: 24098814
Mol Microbiol. 1996 Jun;20(6):1211-20
pubmed: 8809773
mSphere. 2018 Dec 5;3(6):
pubmed: 30518675
Vaccine. 2018 Jan 2;36(1):29-35
pubmed: 29183735
MMWR Recomm Rep. 2020 Sep 25;69(9):1-41
pubmed: 33417592
Hum Vaccin. 2010 Dec;6(12):1025-7
pubmed: 21150271
BMC Genomics. 2016 Oct 28;17(1):843
pubmed: 27793092
Methods Mol Biol. 2012;799:21-35
pubmed: 21993637
J Infect Dis. 2018 Jan 30;217(4):608-616
pubmed: 29155998
J Infect Dis. 2003 May 15;187(10):1616-28
pubmed: 12721942
Lancet. 1999 Mar 20;353(9157):941-2
pubmed: 10459897
Int J Med Microbiol. 2006 Nov;296(7):475-84
pubmed: 16876478
Clin Infect Dis. 2017 Apr 15;64(8):1115-1122
pubmed: 28158417
J Infect Dis. 2015 Jun 1;211(11):1761-8
pubmed: 25505298
J Comput Biol. 2017 Nov;24(11):1138-1143
pubmed: 28715235
J Clin Microbiol. 2019 Feb 27;57(3):
pubmed: 30567750
Vaccine. 2014 Sep 29;32(43):5677-80
pubmed: 25148776
Nature. 2013 Oct 10;502(7470):237-40
pubmed: 24067614
J Med Microbiol. 2004 Sep;53(Pt 9):821-832
pubmed: 15314188
PLoS One. 2017 Sep 20;12(9):e0185038
pubmed: 28931058
Crit Rev Microbiol. 2016 Sep;42(5):759-72
pubmed: 26089023
Pediatr Infect Dis J. 2015 Nov;34(11):1267-9
pubmed: 26222062
Lancet. 2014 Dec 13;384(9960):2123-31
pubmed: 25145775
PLoS One. 2015 Aug 31;10(8):e0135497
pubmed: 26322796
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):271-6
pubmed: 8990198
Hum Vaccin Immunother. 2018 May 4;14(5):1070-1074
pubmed: 29584565
Emerg Infect Dis. 2017 Jun;23(6):1009-1011
pubmed: 28518025
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Clin Microbiol Infect. 2017 Aug;23(8):573.e1-573.e7
pubmed: 28192234
Expert Rev Anti Infect Ther. 2011 Sep;9(9):761-74
pubmed: 21905785
Hum Vaccin Immunother. 2019;15(4):987-994
pubmed: 30513251
J Clin Microbiol. 2014 Jun;52(6):1901-10
pubmed: 24648565
BMC Microbiol. 2017 Feb 21;17(1):40
pubmed: 28222677
J Clin Microbiol. 2004 Jan;42(1):320-8
pubmed: 14715772
PLoS One. 2011 May 05;6(5):e19361
pubmed: 21573213
Wellcome Open Res. 2018 Sep 24;3:124
pubmed: 30345391
Emerg Infect Dis. 2013 Apr;19(4):566-73
pubmed: 23628376
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D32-6
pubmed: 16381877
PLoS One. 2010 Feb 25;5(2):e9413
pubmed: 20195528
Open Forum Infect Dis. 2019 Apr 15;6(5):ofz190
pubmed: 31123695

Auteurs

Melissa J Whaley (MJ)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Jeni T Vuong (JT)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Nadav Topaz (N)

CDC Foundation Field Employee assigned to the Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

How-Yi Chang (HY)

IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Jennifer Dolan Thomas (JD)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Laurel T Jenkins (LT)

IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Fang Hu (F)

IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Susanna Schmink (S)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Evelene Steward-Clark (E)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Marsenia Mathis (M)

IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Lorraine D Rodriguez-Rivera (LD)

IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Adam C Retchless (AC)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Sandeep J Joseph (SJ)

IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Alexander Chen (A)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Anna M Acosta (AM)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Lucy McNamara (L)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Heidi M Soeters (HM)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Sarah Mbaeyi (S)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Henju Marjuki (H)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Xin Wang (X)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Classifications MeSH